Yale Cancer Center

https://www.yalecancercenter.org/

 

Yale Cancer Center
Avatar

Advancing Cancer Treatment by Aldehyde Dehydrogenase Inhibitors

By Yale Cancer Center FEATURING Vasilis Vasiliou
By Yale Cancer Center FEATURING Vasilis Vasiliou
0 views
August 23, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy
General Oncology
51:52
Yale Cancer Center

Investigating the Complex Biology of Drug Resistance for Clinical Im…

Feat. K. Politi
44:56
Yale Cancer Center

Smilow Shares: What's My Cancer Risk? Understanding Genetic Ris…

Feat. C. Nestler
23:26
Yale Cancer Center

GI Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Th…

Feat. C. Balch
21:43
Yale Cancer Center

The Role of Surgery After Neoadjuvant Systemic Therapy for Cancer

Feat. C. Balch
22:18
Yale Cancer Center

Melanoma Updates: The Role of Surgery After Neoadjuvant Systemic The…

Feat. C. Balch
16:07
Yale Cancer Center

Breast Cancer Updates: The Role of Surgery After Neoadjuvant Systemi…

Feat. C. Balch
10:55
Yale Cancer Center

Lung Cancer Updates: The Role of Surgery After Neoadjuvant Systemic …

Feat. C. Balch
48:29
Yale Cancer Center

Therapeutic Targeting of Epigenetic Mechanisms in Cancer

Feat. S. Armstrong
45:56
Yale Cancer Center

Endocrine Adverse Events From Checkpoint Inhibitors

Feat. K. Herold
43:30
Yale Cancer Center

Exploring Environmental Health: Insights From the Yale Superfund Res…

Feat. V. Vasiliou
45:04
Yale Cancer Center

Losses of Nuclear Integrity Tie DNA Damage to Innate Immune Signaling

Feat. M. King
33:54
Yale Cancer Center

Osteolytic Skeletal Metastases: AORIF as a New Strategy for Enhanced…

Feat. F. Lee
48:12
Yale Cancer Center

Lymphocytes as a "Living Drug" for the Treatment of Cancer

Feat. S. Rosenberg
45:52
Yale Cancer Center

Disability as Diversity in Medicine

Feat. P. Poullos
51:13
Yale Cancer Center

The Second Century in the Land of Neuroendocrine Tumors

Feat. J. Yao
33:54
Yale Cancer Center

Peritoneal Surface Malignancies: Novel Therapeutics and Insights

Feat. K. Turaga
50:33
Yale Cancer Center

When Watson and Crick Get Linked: DNA Interstrand Crosslink Repair a…

Feat. A. Smogorzewska
52:53
Yale Cancer Center

The Minor Spliceosome: Exploring Novel Cancer Vulnerabilities

Feat. M. Rubin
49:24
Yale Cancer Center

Using and Improving the Real-World Data Ecosystem in Cancer

Feat. J. Warner
22:48
Yale Cancer Center

Cell Therapy DART at Yale Cancer Center: CAR-T Cells & Adoptive …

Feat. M. Hurwitz
07:14
Yale Cancer Center

The Growth and Development of the Yale CAR-T Cell Therapy Program: W…

Feat. I. Isufi
09:15
Yale Cancer Center

Cancer Anti-CD19 CAR-T Cell Products on the Market: What Are the Res…

Feat. I. Isufi
10:55
Yale Cancer Center

The Yale CAR-T Cell Therapy Program: What Trials Are Underway? What …

Feat. I. Isufi
17:41
Yale Cancer Center

Single-Site Case Series of Symptom Management in Cancer Care: What A…

Feat. R. Lim
37:17
Yale Cancer Center

Checkpoint Inhibitor-Induced Autoimmune Diabetes: Which Antibodies A…

Feat. K. Herold
22:59
Yale Cancer Center

Immune Response to COVID-19: What is the Observed WBC and Moncyte Co…

Feat. A. Iwasaki
08:21
Yale Cancer Center

COVID-19 in Cancer Patients: What Can We Expect to Observe in Transm…

Feat. A. Iwasaki
46:54
Yale Cancer Center

Oncology Clinical Research Overhaul: How Can We Improve the Mechanic…

Feat. H. Krumholz
22:12
Yale Cancer Center

LncRNAs in Cancer: Cause or Consequence?

Feat. N. Dimitrova
26:54
Yale Cancer Center

IO Mechanisms of Cancer Resistance: What Is the Efficacy of CPIs in …

Feat. J. Ishizuka
20:11
Yale Cancer Center

Advancing Cancer Treatment by Aldehyde Dehydrogenase Inhibitors

Feat. V. Vasiliou
17:22
2018 Yale Pancreas Symposium

Refining the Whipple Procedure: Yale Contributions

Feat. R. Salem
27:47
Yale Cancer Center

The Impact of Alternative and Complementary Medicine Use on Cancer S…

Feat. S. Johnson
28:58
Yale Cancer Center

Circulating Tumor DNA as an Immunotherapy Biomarker

Feat. A. Patel
32:31
Yale Cancer Center

Exploiting Oncometabolite-Induced BRCAness

Feat. R. Bindra
25:49
Yale Cancer Center

Manifold Learning Yields Insights on High Dimensional Single Cell Da…

Feat. S. Krishnaswamy
27:02
Yale Cancer Center

T Cell Migration, Function and Residency in Cancer Immunobiology

Feat. A. Iwasaki
22:29
Yale Cancer Center

Human Papillomavirus: From Basic Mechanisms to a New Antiviral Parad…

Feat. D. DiMaio
23:47
Yale Cancer Center

HIV in Advanced Age: UNCHARTED TERRITORY

Feat. A. Justice
26:36
Yale Cancer Center

Clinical Research Support Laboratory - How We Make Research Happen

Feat. S. Halene
31:25
Yale Cancer Center

Cancer Immunotherapy: The End of the Beginning

Feat. S. Chen
32:16
Yale Cancer Center

Genome Editing Approaches for Oncology Discovery and Immune Engineer…

Feat. S. Chen
27:21
Yale Cancer Center

Oncogenic Herpesviruses: New Insights Into Mechanisms Regulating Syn…

Feat. A. Guindy